Skip to main content
TipRanks
Go Ultimate75% OFF

SkinBioTherapeutics (SBTX) Income Statement

26 Followers

SkinBioTherapeutics Income Statement

Last quarter (Q2 2025), SkinBioTherapeutics's total revenue was £2.17M, an increase of 1932.30% from the same quarter last year. In Q2, SkinBioTherapeutics's net income was £-794.26K. See SkinBioTherapeutics’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementJun 24Jun 23Jun 22Jun 21Jun 20
£ 4.64M£ 1.21M£ 132.06K£ 74.76K£ 0.00
£ 2.71M£ 683.04K£ 85.19K£ 45.34K£ -5.05K
£ 3.53M£ 3.59M£ 3.08M£ 3.03M£ 1.49M
Depreciation and Amortization£ 426.60K£ 175.97K£ 44.19K£ 29.67K£ 5.05K
£ -196.54K£ -2.72M£ -2.96M£ -2.95M£ -1.49M
£ -826.79K£ -2.90M£ -3.00M£ -2.98M£ -1.49M
£ 111.67K£ -43.76K£ -8.89K£ -10.13K£ -3.68K
£ -715.12K£ -2.95M£ -3.01M£ -2.99M£ -1.50M
£ -696.25K£ -2.88M£ -2.84M£ -2.79M£ -1.43M
Per Share Metrics
Basic EPS£ 0.00£ -0.02£ -0.02£ -0.02£ -0.01
Diluted EPS£ 0.00£ -0.02£ -0.02£ -0.02£ -0.01
Weighted Average Shares Outstanding227.87M186.29M164.71M156.78M146.70M
Weighted Average Shares Outstanding (Diluted)227.87M186.29M164.71M156.78M146.70M

Currency in GBP

SkinBioTherapeutics Earnings and Revenue History

-4M04M8M-4500 %-3000 %-1500 %0 %EarningsProfit Margin20172018201920202021202220232024RevenueEarningsProfit Margin